Novel anticancer compounds

Details for Australian Patent Application No. 2002351814 (hide)

International Classifications

Event Publications

20 March 2003 Complete Application Filed

Priority application(s): 60/335,300 31.10.01 US

10 July 2003 Application Open to Public Inspection

Published as AU-A-2002351814

18 May 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

25 May 2006 Corrigenda

Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2002 Delete all reference to Application No. 2002351814 Corrigenda

15 June 2006 Assignment before Grant

Morphochem Aktiengesellschaft fur Kombinatorische Chemie The application has been assigned to Nexus Pharma Inc. Assignments before Grant, Section 113

28 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.